Skip to main content
Molecular Biology of the Cell logoLink to Molecular Biology of the Cell
. 2001 Oct;12(10):3268–3281. doi: 10.1091/mbc.12.10.3268

RhoA-dependent Switch between α2β1 and α3β1 Integrins Is Induced by Laminin-5 during Early Stage of HT-29 Cell Differentiation

Stéphanie P Gout †,*, Muriel R Jacquier-Sarlin †,*,, Laurence Rouard-Talbot , Patricia Rousselle §, Marc R Block
Editor: Richard Hynes
PMCID: PMC60172  PMID: 11598208

Abstract

Integrin-mediated interactions between the basement membrane and epithelial cells control the differentiation of epithelia. We characterized the modulation of adhesive behaviors to basement membrane proteins and of integrin function in the human colon adenocarcinoma HT-29 cell line, which differentiates into enterocytes after the substitution of galactose for glucose in the medium. We demonstrate an increased capability of these cells to adhere to collagen type IV during the early stage of differentiation. This effect occurs without any changes in integrin cell surface expression but rather results from an α2β1/α3β1 integrin switch, α3β1 integrin becoming the major collagen receptor. The increase in laminin-5 secretion and deposit on the matrix is a key factor in the mechanism regulating cell adhesion, because it is responsible for the activation of α3β1 integrin. Furthermore, down-regulation of RhoA GTPase activity occurs during HT-29 cell differentiation and correlates with the activation of the integrin α3β1. Indeed, C3 transferase, a RhoA GTPase inhibitor, induces a similar α2β1/α3β1 switch in undifferentiated HT-29 cells. These results indicate that the decrease in RhoA activation is the biochemical mechanism underlying this integrin switch observed during cell differentiation. The physiological relevance of such modulation of integrin activity in the functioning of the crypt-villus axis is discussed.

INTRODUCTION

Epithelial cells are characterized by particular structural features, including polarized morphology and specialized cell-cell contacts. They lie on a basement membrane, which is organized into a complex structure containing collagen type IV (CO IV), various laminin isoforms, and proteoglycans (Simon-Assmann et al., 1995; Aumailley and Krieg, 1996; Beaulieu 1997). Interactions between cells and this specialized extracellular matrix are crucial for essential biological processes such as migration, proliferation, differentiation, and cell survival. The cell–cell or cell–extracellular matrix interactions are mediated through various transmembrane receptors, which are linked intracellularly to cytoskeleton components and signal transduction molecules (Miyamoto et al., 1995; Schwartz et al., 1995). The first receptor family identified was the integrin family (Ruoslahti, 1991; Hynes, 1992). Integrins are heterodimeric transmembrane glycoproteins composed of an α- and a β-subunit. The nature of both the α- and the β-subunit in the heterodimers determines its extracellular matrix ligand specificity.

Laminins include a family of T-shaped heterotrimeric molecules composed of an α, β, and γ chain. At least 12 different isoforms of laminin have been described. These different isoforms can trigger distinct cell responses (Vachon and Beaulieu, 1995; Baker et al., 1996; De Arcangelis et al., 1996; Green and Jones, 1996; Lampe et al., 1998). Epithelial cells adhere to laminin-5 (LN 5) of the basement membrane via at least two adhesive structures, focal adhesions and hemidesmosomes, that involve α3β1 and α6β4 integrins, respectively (Carter et al., 1990a; DiPersio et al., 1995; Dogic et al., 1998). These differences in cellular localization also reflect differences in adhesion-related functions and activation of distinct signal transduction pathways (Carter et al., 1990b; Jewell et al., 1995; Mainiero et al., 1995; Xia et al., 1996). Not only is the integrin α3β1 a receptor for LN 5, but also it recognizes a variety of other ligands with a lower affinity, including fibronectin, CO IV, entactin/nidogen, and thrombospondin (Wayner and Carter, 1987; Elices et al., 1991; Dedhar et al., 1992; Kühn and Eble 1994; DeFreitas et al., 1995). The existence of different binding sites on the α3β1 integrin and of different isoforms of α3 (Tamura et al., 1991) could explain the broad binding specificities of the α3β1 integrin. The physiological significance of these weaker interactions is poorly understood, nevertheless they may reflect different adhesion-related functions, themselves correlated with distinct subcellular localizations. The α3β1 integrins can be targeted to cell-cell junctions, where they may have a role in maintaining cell-cell adhesion or in promoting gap junctions (Carter et al., 1990b; Lampe et al., 1998). Otherwise, this integrin is found along the basolateral membrane of many epithelial cell types, suggesting that it functions as a basement membrane receptor. Interestingly, in keratinocytes the integrin α3β1 is not detectable in focal adhesions on LN 5 (DiPersio et al., 1995). Formation of focal adhesions and the closely associated actin stress fibers requires the activation of the small GTP-binding protein RhoA (Ridley and Hall, 1992). RhoA is a member of the Ras superfamily, which cycles between a GDP-bound inactive state and a GTP-bound active state. This suggests that α3β1-mediated interactions may differ from other integrins by signaling through RhoA. However, studies of cells and tissues deficient in α3β1 indicate a more complex role of this integrin in modulating adhesion, migration, and cytoskeleton organization (Wang et al., 1999; Kreidberg, 2000). Indeed, α3β1 has been described as a trans-dominant inhibitor of fibronectin, CO IV, and laminin integrin receptors (Lichtner et al., 1998; Dogic et al., 1998; Hodivala-Dilke et al., 1998; Laplantine et al., 2000). This regulatory function may be relevant for the multiple roles that have been ascribed to the integrin α3β1, in particular in cell growth and in keratinocyte differentiation (Symington and Carter, 1995; Gonzales et al., 1999).

The intestinal epithelium is in constant and rapid renewal, thus representing an attractive system to study the influence of cell-basement membrane interactions in the control of cell differentiation. Indeed, the crypt-villus axis is a functional unit where proliferative, differentiated, and senescent cells are topologically restricted to two distinct compartments: the crypts that contain stem cells and dividing cells, and the villi that protrude into the lumen and are composed of differentiated cells that migrate to the villus tip where they are extruded. (Leblond, 1981; Louvard et al., 1992). Originating from a human colon adenocarcinoma, HT-29 cells appear to be a useful in vitro model to study the different aspects of cell differentiation, because their degree of differentiation and polarization can be modulated in vitro under specific culture conditions. The establishment of a differentiated state of HT-29 cells is obtained by a simple change of the carbon source in the culture medium (Pinto et al., 1982; Zweibaum et al., 1985; Wice et al., 1985). By analogy with the human crypt-villus axis, it has been proposed that 1) HT-29 cells cultured in glucose have properties of undifferentiated multipotent cells located at the lower half of intestinal crypts, 2) proliferating HT-29 cells cultured in inosine or galactose resemble committed cells located at the upper half of the crypt, and 3) confluent HT-29-inosine or HT-29-galactose cells have features of terminally differentiating villus-associated enterocytes (Huet et al., 1987).

The homeostasis of this highly specialized and actively proliferating epithelium depends on a tightly controlled cellular microenvironment. Both basement membrane molecules and growth factors trigger signaling pathways, which are closely interconnected. Among the basement membrane molecules, laminins present the highest variability in their spatial and temporal expression either during intestinal development or in the adult (Timpl, 1996; Simon-Assmann et al., 1994, 1998; Simoneau et al., 1998; Ekblom et al., 1998). In the present work we have found that modifications of LN 5 expression control integrin receptor-mediated cell adhesion of human HT-29 cells during the early stage of differentiation.

MATERIALS AND METHODS

Antibodies and Cell Adhesion Substrates

The function-blocking anti-integrin monoclonal antibodies (mAbs) used were GoH3 against α6 integrin, P1B5 and ASC1 against α3 integrin, and BHA2.1 against α2β1, all from Chemicon (Euromedex, Souffelweyersheim, France); and P4C10 and K20 against β1 integrin (Life Technologies, Cergy Pontoise, France). Other mAbs were anti-laminin α3 chain, BM165 (Rousselle et al., 1991; Rousselle and Aumailley, 1994); anti-major histocompatibility complex (MHC) class II molecules, L243 was a gift of Dr P. Bénaroche (Paris, France); and goat anti-IgG2a, U7.27 (Immunotech, Marseille, France). Alexa- or horseradish peroxidase-conjugated goat antimouse antibodies from Molecular Probes (Eugene, OR) and Bio-Rad (Hercules, CA), respectively, were used as secondary antibodies in most experiments. Human collagen type IV from placenta was obtained from Life Technologies. Bovine plasma fibronectin was purified according to the method of Engvall and Ruoslahti (1977). Laminin 5 purified from the culture medium of human SCC25 was kindly provided by Dr P. Rousselle (Institut de biologie et chimie des proteines, Lyon, France).

Cell Culture

The human colonic adenocarcinoma HT-29 cell line (kindly provided by Pr. Marvaldi, Marseille, France) was routinely cultured at 37°C in a 5% CO2 atmosphere in DMEM containing 25 mM glucose (Life Technologies) supplemented with 10% fetal calf serum, and penicillin-streptomycin (Glu medium or standard medium). The medium was changed every day to avoid glucose exhaustion, which could induce differentiation (Pinto et al., 1982). The differentiation of HT-29 cells was initiated by replacing Glu medium with glucose-free DMEM (Life Technologies) supplemented with 10% dialyzed fetal calf serum, 5 mM galactose, 15 mM HEPES, selenous acid (10−2 μg/ml), penicillin, and streptomycin. The medium (Gal medium or differentiating medium) was changed every day. The cells were harvested with phosphate-buffered saline (PBS) supplemented with 1 mM EDTA and 0.05% trypsin (wt/vol).

Isolation of Membrane and Enzymatic Assay

The membrane fractionation procedure was adapted from Stieger et al. (1986). Briefly, the cells were resuspended in buffer B (5 mM Na2SO4, 1 mM Tris/HCl, pH 7.6, 40 μg/ml phenylmethylsulfonyl fluoride) and sonicated for 30 s at 4°C. Then the homogenate was centifuged for 7 min at 1060 × g. The pellet was resuspended in buffer B by shaking the tubes very gently and recentrifuged for 7 min at 2200 rpm. The pellet was resuspended in buffer B and Percoll was added to a final concentration of 10% (vol/vol). Spinning the tubes for 20 min at 37,000 × g formed the gradients. The supernatant was discarded and fractions containing the brush-border–enriched membrane were collected from the surface of the glassy Percoll pellet by careful resuspension in water. Alkaline phosphatase was measured in 0.05 M glycine pH 10.5, 0.2 mM MgCl2, 5 mM CaCl2 and 2 mM zinc acetate with 10 mM p-nitrophenylphosphate disodium salt as substrate. The reaction was carried out in a volume of 1.2 ml in a water bath at 37°C for 2 h and terminated by the addition of 200 μl of 10 N NaOH. The production of p-nitrophenol was estimated by measuring the optical density at 420 nm.

Cell Adhesion and Inhibition Assays

Microtiter plates (96-well, Nunclone; Nunc, Roskilde, Denmark) were coated overnight at 4°C with CO IV (Sigma, St. Louis, MO) at a concentration of 5 μg/ml in PBS. Plates were subsequently saturated with 3% (wt/vol) bovine serum albumin (BSA) in PBS for 2 h at 37°C to block nonspecific adhesion. HT-29 cells and HT-29 cells cultured 10 days in Gal medium (HT-29 Gal) were preincubated in serum-free DMEM for 3 h at 37°C. Then 5 × 104 cells/well were plated in triplicate in coated 96-well microtiter plates and incubated for 60 min at 37°C. Nonadherent cells were removed by washing three times with PBS, and cell adhesion was estimated by a colorimetric cell proliferation assay (CellTiter 96 AQueous Nonradioactive Cell Proliferation Assay; Promega, Madison, WI). In inhibition assays, the cells were preincubated with the appropriate dilution of antibodies for 30 min before plating onto coated plates for a 60-min adhesion assay. Some adhesion assays were performed after treatment with various RhoA protein modulators. Lysophosphatidic acid (LPA; Sigma), an activator of Rho protein, was added to cell samples 15 min before adhesion at concentrations ranging from 0–10 mM. The C3 transferase assay (gift from Dr. P. Boquet, INSERM 652, UFR de Medecine, Nice, France) was added to the culture medium at 108 M overnight before the cell adhesion. LPA and C3 transferase were removed before cell adhesion assays.

Flow Cytometry

Cell monolayers were harvested with trypsin-EDTA solution, washed twice in PBS, and fixed for 10 min at 37°C with 4% (wt/vol) paraformaldehyde in PBS. The cells were first incubated under gentle rotation with negative control mAb (IgG2A isotype) or specific mAb, for 1 h at room temperature. Then the cells were incubated with Alexa 488-goat antimouse IgG for 45 min at room temperature before fluorescence-activated cell sorting (FACS) analyses (FACScan; Becton Dickinson Biosciences, Mountain View, CA, and the FACStar research software program, Lysis II). Washing with PBS containing 0.05% (wt/vol) Tween 20 eliminated the excess antibodies. Fluorescence with negative control mAb was subtracted to give specific mean fluorescence intensity units.

Quantification of Secreted Laminin-5, Embedded into Insoluble Matrix

HT-29 cells cultured in standard medium or HT-29 cells cultured for 2–10 days in Gal medium (5 × 104 cells/well) were incubated in a Microtiter plate (96-well, Nunclone). The medium was changed every day. After 48 h the cells were lyzed in 20 mM NH4OH for 15 min at 37°C. Then the plate was washed three times with distilled water and twice with PBS. After saturation with PBS-3%BSA, the LN 5 secreted onto the matrix was estimated by an enzyme-linked immunosorbent assay with the use of BM165 mAb (1/1000 of hybridoma supernatant from culture medium) for 60 min at 37°C. Detection was performed with a rabbit antimouse conjugated with horseradish peroxidase and 2,2′-azino-di (3-ethyl-benzothiazoline-6 sulfonic acid) (Zymed Laboratories, South San Francisco, CA) as substrate. Nothing has been detected in the soluble phase by this method. All experimental conditions were performed in triplicate.

Immunocytochemical Detection of Secreted Laminin-5, Embedded into Insoluble Matrix

HT-29 cells or HT-29 Gal cells (cultured 10 days in Gal medium) were incubated 48 h on glass coverslips. Immunodetection of LN 5 deposited on the glass coverslip was performed after removal of the cells after a 1-h treatment with a solution containing 1% Triton X-100, 10 mM EDTA, and 25 mM Tris-HCl, pH 7.5. Then coverslips were washed three times with PBS and fixed with 3% (wt/vol) paraformaldehyde, 2% (wt/vol) sucrose for 10 min at 37°C. After incubation for 1 h at room temperature with blocking solution (10% [vol/vol] goat serum in PBS) to reduce background signal, LN 5 was detected with mAb BM165 diluted (1/50) in blocking solution (1 h at 37°C). After washing in PBS-0.05% (wt/vol) Tween 20, detection was continued with an anti-mouse conjugated to Alexa 488 for 45 min at 37°C. Coverslips were permanently mounted with Mowiol (Calbiochem, Meudon, France). Fluorescence photomicrographs were made with the use of a Zeiss Axiophot microscope (Carl Zeiss, Jena, Germany) equipped with epifluorescence and a Zeiss 63× objective, coupled to a Hamamatsu (Bridgewater, NJ) charge-coupled device camera C4880.

RhoA Activity Assay

RhoA activity was estimated with the use of the Rho-binding domain of Rhotekin as described (Ren et al., 1999). Briefly, HT-29 and HT-29 Gal cells (5 × 106) were lyzed with RIPA buffer (50 mM Tris, pH 7.2, 500 mM NaCl, 1% Triton X-100, 0.5% deoxycholate, 1% SDS, 10 mM MgCl2, and a cocktail of proteases inhibitors). In some experiments HT-29 cells were adhered on LN 5 (20 μg/ml) 30 min before cell lysis. After centrifugation at 14,000 × g for 5 min, the extracts were incubated for 45 min at 4°C with glutathione beads coupled with bacterially expressed recombinant GST-RBD (Rho-binding domain of Rhotekin) fusion protein (kindly provided by Martin Schwartz, Scripps Research Institute, La Jolla, CA) and then washed three times with Tris buffer, pH 7.2, containing 1% Triton X-100, 150 mM NaCl, and 10 mM MgCl2. The RhoA content in these samples was determined by immunoblotting samples with the use of rabbit anti-RhoA antibodies (Santa Cruz Biotechnology, Santa Cruz, CA).

RESULTS

Culture in Glucose-free Medium (Gal Medium) Initiated Differentiation of HT-29 Cells

Substitution of galactose for glucose in the culture medium (Gal medium) of HT-29 cells has been described to induce a reversible enterocytic differentiation of these cells. The acquisition of the epithelial phenotype by HT-29 cells induced by Gal medium took several days and was evaluated by two approaches: the comparison of morphological changes by phase contrast microscopy (Figure 1A) and the determination of the specific activity of alkaline phosphatase in membrane-enriched fractions (Figure 1B). The microscopic observation showed that in standard medium, the cells appeared disorganized and grew in multilayers at confluence. In contrast, cells cultured in Gal medium (HT-29 Gal cells) were committed to differentiation: they became flattened and grew in monolayer (Figure 1A). Transmission electron microscopy indicated that HT-29 Gal cells developed microvilli that were partially organized into brush-border structures (data not shown). This phenotype corresponds to the early phase of cell differentiation (10 days after seeding). During cell differentiation, it has been described that the maturation of brush-border hydrolases, such as alkaline phosphatase parallels the exhibition of an apical domain covered with microvilli. An increase in the alkaline phosphatase activity was observed during the time course of the culture in Gal medium. After 10 days, HT-29 cells showed a threefold higher alkaline phosphatase activity compared with control cells (Figure 1B). Taken together, our data indicate that in Gal medium, HT-29 cells initiate a process of epithelial differentiation.

Figure 1.

Figure 1

Induction of HT-29 cell differentiation. (A) Phase-contrast images of HT-29 cells grown in standard medium (left, HT-29) or in Gal medium for 10 days (right, HT-29 Gal). Bar, 100 μm. (B) Correlation between alkaline phosphatase activity and the day of culture in Gal medium. Membrane-enriched fractions were isolated from HT-29 cells grown for 2, 4, 6, 8, and 10 days in Gal medium and assayed for alkaline phosphatase activity as described in MATERIALS AND METHODS. The specific activity, which is reported in milli-unit per milligram (mU/mg) of protein, increased with the time of culture in Gal medium. The data were compiled from three independent assays; error bars represent SE values of the mean.

Increased Adhesion to CO IV Occurs during HT-29 Cell Differentiation

A modulation of cell basement membrane interactions has been described during the differentiation of intestinal cells that occurs along the crypt-villus axis. Because CO IV is an important component of the basement membrane, we analyzed the ability of HT-29 cells to adhere to this matrix protein depending on the time of culture in Gal medium up to the early differentiation stage. Figure 2 shows a time-dependent increase in cell adhesion to CO IV. Although HT-29 cells cultured in standard medium adhered poorly to CO IV, 69% of cells cultured for 10 days in the differentiating medium adhered to this protein. The adhesion capacity of HT-29 cells increased twofold after 6 days of culture in Gal medium, in correlation with the appearance of differentiation markers such as hydrolases (Figure 1B) and of carcinoembryonic antigen (Fantini et al., 1989).

Figure 2.

Figure 2

Adhesive behavior on Co IV of HT-29 cells grown in Gal medium. Cells grown for 2, 4, 6, 8, and 10 days in Gal medium were allowed to attach to 5 μg/ml CO IV. Adhesion was estimated with the use of a Cell Titer Aqueous MTT reagent kit and expressed as a percentage of adherent cells. Depending on the time of culture in Gal medium, the percentage of HT-29 cells adhering to CO IV increased. The experiment was done in triplicate and repeated four times.

Switch from α2β1 to α3β1-mediated Cell Adhesion to CO IV in Early State of HT-29 Differentiation

Many β1 integrins were described as putative collagen receptors, including α1β1, α2β1, and with a lower affinity, α3β1. To determine which integrins were predominantly involved in CO IV-mediated adhesion of HT-29 and HT-29 Gal cells, we performed adhesion assays in the presence or absence of inhibitory mAbs against specific integrins (Figure 3A). Incubation with antibodies directed against the β1 subunit resulted in an 80% inhibition of both HT-29 and HT-29 Gal cell adhesion to CO IV, confirming that β1 integrins are the major receptors for this protein. Similar experiments were carried out with antibodies specific for α2β1 and/or the α3β1 integrins. In the presence of anti-α2β1 antibodies only 4.9% of HT-29 cells adhered to CO IV (adhesion was blocked by 77%), whereas 65% of HT-29 Gal cells remained adherent (adhesion was blocked by 9%). Conversely, when anti-α3β1 antibodies were used, 16.5% of HT-29 cells adhered to CO IV (adhesion was blocked by 12%) versus 22.5% for HT-29 Gal cells (adhesion was blocked by 68%). Combination of antibodies directed against both the α2β1 and the α3β1 integrins gave similar results to those obtained with anti-β1, i.e., ∼80% inhibition for both culture conditions. Finally, antibodies directed against the α6 integrin, which is predominantly involved in cell adhesion to LN 5, had no significant effect on cell adhesion to CO IV.

Figure 3.

Figure 3

Inhibition of HT-29 and HT-29 Gal cell adhesion to Co IV by anti-integrin antibodies. (A) Before adhesion to CO IV (5 μg/ml), HT-29 and HT-29 Gal cells were incubated for 45 min with various mAbs directed against integrin subunits at a concentration of 10 μg/ml: P4C10 (anti-β1), BHA2.1 (anti-α2β1), P1B5 (anti-α3), and GoH3 (anti-α6). Although HT-29 cell adhesion was mostly mediated by α2β1, a collagen receptor switch to α3β1 is observed in HT-29 Gal cells. (B) Before adhesion assays, cells grown for 2, 4, 6, 8, and 10 days in Gal medium were incubated for 45 min with 10 μg/ml anti-α2 β1 or anti-α3 blocking mAbs. The switch from α2β1 to α3β1 as collagen receptor occurred after 6 days of culture in Gal medium. The experiment was performed in triplicates and repeated three times.

The fact that α3β1 integrin contributes to HT-29 Gal but not to HT-29 cell adhesion to CO IV suggested that a switch in collagen receptors occurs during HT-29 cell differentiation. To test this hypothesis, we used function-blocking antibodies to identify the integrin receptor involved in CO IV adhesion depending on the days of culture in Gal medium (Figure 3B). During the first 2 d of culture in the differentiation medium, adhesion of HT-29 cells to CO IV was mostly mediated by α2β1 (70% inhibition with anti-α2β1 compared with 5% with anti-α3). After 6 days of culture in Gal medium, both integrins were equally involved in HT-29 cell adhesion to CO IV. Beginning with the 8th days of culture, α3β1 integrin became the major receptor of HT-29 involved in cell adhesion to CO IV (80% inhibition with anti-α3 compared with 30% with anti-α2β1 after 10 days of culture in Gal medium). Thus, it appeared that the differentiation of HT-29 cells was indeed associated with a switch in the collagen receptors from integrin α2β1 to α3β1, which was accompanied by an overall increase in cell adhesion to CO IV.

α3β1 Surface Expression Is not Modified During Early Stage of HT-29 Differentiation

To investigate whether the differences in adhesion to CO IV between HT-29 and HT-29 Gal cells could result from changes in the surface expression levels of integrins, the cells were stained with anti-integrin antibodies and analyzed in flow cytometry assays (Figure 4). Concerning the β1, α2β1, or α3β1 integrins, no significant changes in the levels of surface expression were found, indicating that HT-29 cell differentiation did not modify the integrin expression profiles.

Figure 4.

Figure 4

FACS analysis of expression levels of β1, α2, and α3 integrin subunits in HT-29 and HT-29 Gal cells. FACS profiles of HT-29 and HT-29 Gal cells stained with anti-integrin antibodies at a concentration of 10 μg/ml: P4C10 (anti-β1), BHA2.1 (anti-α2β1), P1B5 (anti-α3), or goat anti-IgG2a (negative control). The negative controls (dotted line) indicated the staining background levels. Specific mean fluorescence intensity (MFI) values are indicated. HT-29 and HT-29 Gal cells expressed similar level of β1, α2, and α3 integrin subunits.

α3β1 Integrin Becomes Major CO IV Receptor after Being Activated

Because α3β1 mediated-adhesion of HT-29 Gal cells to CO IV did not result from a modulation of its surface expression, we hypothesized that in HT-29 Gal cells α3β1 had been activated. The presence of activated α3β1 at the cell surface of HT-29 Gal cells was tested by an adhesion assay on LN 5, the major ligand for this integrin. As shown in Figure 5A, the adhesion to LN 5 of HT-29 cells cultured 8 days in Gal medium was twofold higher than that of HT-29 cells cultured in standard medium. To rule out a possible contribution of other integrin-mediated adhesion to LN 5, we performed adhesion assays to LN 5 in presence of blocking function mAbs against specific integrins (Figure 5B). Although HT-29 cells adhesion to LN 5 was mediated by both α3 and α6 integrins (40 and 60% inhibition, respectively), the adhesion of HT-29 Gal cells was mostly mediated by α3β1 integrins (72% inhibition). Thus, it appears that during differentiation of HT-29 cells, the α3β1 integrin becomes activated and increases the capacity of HT-29 cells to adhere to both CO IV and LN 5.

Figure 5.

Figure 5

Adhesive behavior of HT-29 and HT-29 Gal cells on laminin-5. (A) Multiwell plates were coated with different concentrations of LN 5, ranging from 0 to 8 μg/ml. After a saturating step with 3% BSA in PBS, HT-29 and HT-29 Gal cells were allowed to attach for 1 h at 37°C. Cell adhesion was measured and expressed as described in MATERIALS AND METHODS. The data were compiled from three independent experiments; error bars represent SE values of the mean. (B) Before adhesion to LN 5 (4 μg/ml), HT-29, and HT-29 Gal cells were incubated for 45 min with various mAbs directed against integrin subunits at a concentration of 10 μg/ml: P4C10 (anti-β1), BHA2.1 (anti-α2β1), P1B5 (anti-α3), and GoH3 (anti-α6). Although HT-29 cells adhesion to LN-5 was mediated by both α3 and α6 integrins, the adhesion of HT-29 Gal cells was essentially mediated by α3β1 integrins.

The mAb P1B5 has been reported to have various “activating” or “inhibitory” effects according to its concentration on α3β1 function such as tyrosine phosphorylation (Jewell et al., 1995) or cell-cell localization and differentiation (Takeuchi et al., 1994; Symington and Carter, 1995). Thus, we investigated whether triggering of α3β1 by low concentrations of P1B5 (0.5–5 μg/ml) could lead to its activation and consequently modulate adhesion to CO IV matrix, but inhibit the integrin at high concentrations (10–20 μg/ml). HT-29 and HT-29 Gal cells were preincubated for 1 h with different concentrations of P1B5, before adhesion to CO IV (Figure 6A). In the absence of the mAb P1B5, only 23.5% of HT-29 cells adhered to CO IV (Figure 6A, top). At low concentrations of P1B5, the percentage of adherent cells increased progressively to a maximum of 42.8% (at 2 μg/ml P1B5). At higher concentrations of P1B5, the percentage of HT-29 cells adherent to CO IV decreased to 20%, which corresponded to their basal adhesion on this matrix. In HT-29 Gal cells (Figure 6A, bottom), low concentrations of P1B5 already induced an inhibition of cell adhesion (61.6% of cell adhered in the control vs. 30% with 2 μg/ml P1B5), indicating that most α3β1 molecules on these cells were already activated. In contrast to HT-29 cells, high concentrations of P1B5 (20 μg/ml) completely inhibited adhesion of HT-29 Gal cells to CO IV (around 10% of HT-29 Gal cells adhered). Our data indicate that α3β1 became the major collagen receptor (Figure 3). To test whether these mAb-mediated effects on cell adhesion to matrix were specific for P1B5, we performed similar experiments with control antibodies used at the same concentration. With the use of another anti-α3 mAb, ASC1, we found the same results as for P1B5 (Figure 6A). In competition experiments we observed that these two antibodies have overlapping epitopes (data not shown). With the use of two anti-β1 mAbs, we observed no effect on HT-29 cell adhesion to CO IV, whatever the concentration of the nonblocking mAb K20 used, whereas cell adhesion was progressively decreased by increasing concentrations of the function-blocking mAb P4C10 (Figure 6B). Thus, the effect of anti-α3 mAbs appeared to be specific to the epitope of this integrin.

Figure 6.

Figure 6

Effect of the P1B5 antibody on HT-29 cell adhesion to CO IV. (A) When adhesion to CO IV was carried out in the presence of low concentrations of P1B5 or ASC1 (0.5–2 μg/ml; activation concentrations), the adhesion of HT-29 cells was increased. At higher concentrations (10–20 μg/ml; blocking concentrations) P1B5 and ASC1 had no effect on HT-29 cells, in fact both antibodies inhibited HT-29 Gal cell adhesion in a dose-dependent manner. P1B5 and ASC1 share overlapping epitopes on the α3 integrin subunit. (B) Adhesion assays were performed with control antibodies (anti-β1 mAbs) used at the same concentration. Adhesion of HT-29 cells to CO IV was not modified regardless of the concentration of the mAb K20 used; in contrast, cell adhesion decreased progressively upon increasing the concentration of the function blocking mAb P4C10.

Laminin-5 Secretion Is Responsible for Activation of α3β1 during Differentiation of HT-29 Cells

In situ, LN 5 is mostly found in the basement membrane lining the differentiated enterocytes (Simon-Assmann et al., 1998). Furthermore, it has been shown that human colon carcinoma cells synthesize LN 5 (Orian-Rousseau et al., 1998). Therefore, we hypothesized that elevated expression of LN 5 in HT-29 cells cultured in Gal medium could be responsible for the activation of α3β1 integrins.

To test this hypothesis, levels of LN 5 deposited into insoluble matrix from undifferentiated HT-29 cells and HT-29 cells cultured for different time periods in Gal medium were determined by a quantitative solid phase assay. As shown in Figure 7A, the relative deposit of LN 5 increased with the time of culture in Gal medium. After 10 days in Gal medium, the amount of LN 5 synthesized was fivefold higher than in HT-29 cells cultured in standard medium. The immunocytochemical detection of LN 5 deposited on the culture wells confirmed the differential expression of LN 5 in HT-29 and HT-29 Gal cells (Figure 7B). HT-29 Gal cells displayed a regular labeling of LN 5 in basal patches. Conversely, the HT-29 cells deposited only tiny dispersed spots.

Figure 7.

Figure 7

Laminin-5 secretion into insoluble form by HT-29 and HT-29 Gal cells. (A) Quantification of LN 5 secretion into insoluble form by HT-29 cells and HT-29 Gal cells cultured for 2, 4, 6, 8, and 10 days in Gal medium, in a solid phase assay. Laminin-5 was revealed by the BM165 mAb, followed by a goat antimouse mAb coupled to horseradish peroxidase. A time-dependent increase in LN 5 secretion and deposit into the matrix was observed for HT-29 cells cultured in Gal medium. (B) Immunochemical detection of secreted LN 5 by HT-29 and HT-29 Gal cells. HT-29 cells or HT-29 Gal cells (10 days in Gal medium) were cultured 48 h on glass coverslips. After cell removal and fixation as described in MATERIALS AND METHODS, LN 5 deposited on the glass coverslips was immunodetected with a 1/50 diluted BM165 mAb (from cell culture supernatant). Laminin-5, which is organized in strips (parallel lines), is clearly detected in deposits of HT-29 Gal cells, whereas it is barely observed after HT-29 cell cultures. Bar, 35 μm.

To determine whether this differential expression of LN 5 was responsible for the activation of α3β1 integrins, we performed adhesion assays on CO IV after a variable preculture period of HT-29 cells on various extracellular matrix proteins, including LN 5. As shown in Figure 8A, the preculture on fibronectin or plastic did not modulate HT-29 cell adhesion, and ∼18% of the HT-29 cells adhered to CO IV. In contrast, preculture on CO IV for 1–16 h lead to a twofold increase in the number of HT-29 cells adherent to CO IV. Finally, a time-dependent increase in HT-29 adhesion to CO IV was only observed in HT-29 cells precultured on LN 5: after 1 h on LN 5, 50% of cells were able to adhere to CO IV versus 78% after 16 h. Analysis of the integrin receptor(s) involved in collagen adhesion after 16 h of culture on the different matrix proteins was performed with the use of inhibitory antibodies directed against β1, α2, and α3 (Figure 8B). Whatever the matrix used during the preculture, cell adhesion to COIV was mostly mediated by the β1 subunit. However the α subunit associated with β1 to constitute the CO IV receptor differed depending on the nature of the matrix used for preculture of HT-29 cells. After an overnight preculture on plastic or fibronectin, adhesion of HT-29 cells to CO IV was mediated by α2β1 integrin. Similar experiments performed with a CO IV matrix during the preculture step indicated a participation of one-third for α2β1 (31% inhibition with anti-α2β1 mAbs) and two-thirds for α3β1 (62% inhibition with anti-α3 mAbs) in cell adhesion to collagen. Finally, when HT-29 cells were precultured overnight on LN 5, the major CO IV receptor switched to α3β1 integrin. Altogether, our results indicate that LN 5 and to a lesser extent CO IV are able to activate α3β1, which becomes the major collagen receptor, whereas α2β1 is switched off. However, because both α3 and α6 integrins are LN 5 receptors on HT-29 cells (Figure 5), the initiation of the integrin switch by LN 5 could be due either to α3 or α6 integrins.

Figure 8.

Figure 8

Role of LN 5 in α3β1 activation. (A) Modulation of HT-29 cell adhesion to CO IV after preculture on various extracellular matrix proteins. HT-29 cells were seeded on plates coated with various extracellular matrix proteins at 20 μg/ml (FN, fibronectin; CO IV, collagen type IV; LN 5, laminin-5) for 1, 4, or 16 h and then tested for their adhesive behavior to CO IV as described in MATERIALS AND METHODS. Preincubation with CO IV stimulated a twofold increase in cell adhesion. Cell adhesion remained constant during the time of the experiment. Conversely, preincubation with LN 5 led to a time-dependent and stronger increase in adhesion. Results are expressed as the mean ± SE for three wells. (B) Effects of inhibitory mAbs on HT-29 cell adhesion to Co IV after overnight preculture on various extracellular matrix proteins. Cells were precultured overnight on plastic coated with 20 μg/ml various extracellular matrix proteins (FN, CO IV, LN 5) and then tested for adhesion to CO IV after an incubation of 45 min with mAbs directed against integrin subunits as described above. (C) Cell adhesion to CO IV after culture of HT-29 cells in Gal medium in presence of anti-laminin-5 antibody. After 10 days, 5 × 104 living cells were tested for their adhesive capacity to CO IV, as described above. Adhesion of HT-29 Gal cells cultured in the presence of the BM165 mAb was dramatically reduced, whereas culture in presence of the L243 mAb had no effect. Standard: HT-29 cells grown in standard medium. Results are expressed as the mean ± SE for three wells.

To further demonstrate that LN 5 is able to provoke a switch in collagen receptors, HT-29 cells were cultured for 10 days in Gal medium, in the presence or absence of mAbs directed against the α3 subunit of LN 5 (mAbs BM165) or the MHC class II molecules (mAbs L243) before testing their adhesive properties on CO IV. Figure 8C indicates that adhesion of HT-29 cells cultured in Gal medium with mAb L243 was similar to that of HT-29 Gal cells (∼73%). Conversely, only 14% of cells cultured in Gal medium with mAb BM165 had adhered to CO IV, a percentage similar to that of HT-29 cells cultured in standard medium (18%).

Switch from α2β1 to α3β1-mediated Cell Adhesion to CO IV Depends on RhoA Activity

To address the mechanism of the integrin switch during colon epithelial cell differentiation, we examined the differences between HT-29 and HT-29 Gal cell signaling pathways in correlation with CO IV adhesive properties. The α2β1-mediated adhesion to CO IV has recently been described as Rho dependent (Nguyen et al., 2000), so we compared the effect of a modulator of RhoA GTPase activity on the adhesion of both cell lines to CO IV. As a result of treatment for 15 min before adhesion with various concentrations of LPA (an activator of RhoA proteins), adhesion of HT-29 cells cultured in Gal medium to CO IV was inhibited in a dose-dependent manner, suggesting that α3β1 mediating adhesion to COIV is sensitive to the level of active RhoA proteins (Figure 9A). Conversely, the adhesion of HT-29 cells was unaffected by treatment with LPA. In contrast, when C3 transferase was added to the culture medium of HT-29 cells, we noticed an increase in the percentage of cells adhered to CO IV from 17 to 61.8% (Figure 9B). This increased adhesion was mediated by α3β1 integrin because the effect was eliminated by P1B5 mAb. C3 transferase specifically ADP-ribosylates RhoA proteins at Asn41, thereby rendering them inactive (Sekine et al., 1989). Our results strongly suggested that α3β1-mediated adhesion required a low level of active RhoA. With the use of a Rho-GTP pull-down assay, we compared the levels of active RhoA-GTP in HT-29 and HT-29 Gal cells (Figure 9C). It appeared that the RhoA-GTP level was 10-fold higher in HT-29 cells than in differentiated cells. Therefore, our results indicated that the balance of RhoA-GTP levels was responsible for the switch from α2β1- to α3β1-mediated cell adhesion to CO IV. Because LN 5 was responsible for this switch, we investigated the effect of adhesion to LN 5 on RhoA-GTP levels (Figure 9D). Thirty minutes of adhesion to LN 5 is sufficient to induce a decrease (factor 2.5) of RhoA activity.

Figure 9.

Figure 9

RhoA activity controls the switch from α2β1- to α3β1-mediated cell adhesion to CO IV (A and B). Before adhesion to CO IV (5 μg/ml), HT-29 and HT-29 Gal cells were incubated for 3 h, either with LPA at concentration ranging from 0 to 10 mM (A) or overnight with C3 transferase (10−8 M) (B). The cells were then washed with PBS and allowed to attach for 1 h at 37°C. Cell adhesion was measured and expressed as described in MATERIALS AND METHODS. The data were compiled from three to five independent experiments; error bars represent SE values of the mean. In competition experiments cells were incubated with various mAbs directed against integrin subunits at a concentration of 10 μg/ml: P4C10 (anti-β1), BHA2.1 (anti-α2 β1), and P1B5 (anti-α3). (C and D) Western blots showing RhoA activity in HT-29 and HT-29 Gal cells. The levels of RhoA-GTP were also compared for HT-29 cells after 30 min adhesion on LN 5 (20 μg/ml). Colon epithelial cell differentiation is characterized by a decrease in RhoA-GTP levels, even than adhesion to LN 5.

DISCUSSION

Integrin-mediated interactions between epithelial cells and the basement membrane play a crucial role in various biological processes, such as cell proliferation, migration, and differentiation. Studies carried out with both cell cultures and tissues have determined the expression and localization of basement membrane molecules and integrins. The next step is to dissect the precise signaling pathways involved in the cellular response to basement membrane proteins. In the present work we have addressed this basic question by studying, during an early stage of epithelial cell differentiation, the correlation between matrix protein expression and integrin activation and function. Taken together, our data indicate that the initiation of epithelial cell differentiation leads to LN 5-mediated activation of α3β1 integrins, which increases adhesion of HT-29 cells to CO IV; the α3β1 integrin becoming the major collagen receptor, whereas the α2β1 integrin is switched off. This integrin switch depends on the cellular level of activated RhoA.

HT-29 Cells Mimic Enterocyte Differentiation

In our experiments, we induced HT-29 cell differentiation by switching to culture media containing galactose as the source of carbon. The induction of a differentiation process is not due to galactose per se, but rather to the substitution of galactose for glucose, which results in a reduction of hexose consumption and lactic acid production (Eagle et al., 1958). During the process of differentiation, a number of biochemical markers become polarized to the apical membrane such as alkaline phosphatase and the carcinoembryonic antigen (Le Bivic and Arsanto, 1987; Fantini et al., 1989) and could be used as markers of cell differentiation in concert with morphological changes. In our culture conditions (10 days of culture in Gal medium), HT-29 cells were only partially differentiated as judged by morphological and ultrastructural observations but were committed to differentiation according to biochemical analysis showing an increase in the level of alkaline phosphatase activity in membrane-enriched fractions. Furthermore, studies from Fantini et al. (1989) indicated that in a HT-29-derived cell clone, apical carcinoembryonic antigen release into the culture medium starts after 6 days of culture in Gal medium and increases in a time-dependent manner. Full differentiation of HT-29 cells required 21 days of culture in Gal medium.

Switch between α2β1 and α3β1 Integrins Is Associated with a Signaling Pathway Involving RhoA-GTPase Proteins

Previous studies on HT-29 cell adhesion indicated that these cells adhere well to laminin isoforms 1 and 5 and to a lesser extent to CO IV (Schreiner et al., 1991; Orian-Rousseau et al., 1998). The integrins involved in cell adhesion to CO IV have not been precisely defined although they belong to the β1 integrin family (Schreiner et al., 1991). Our functional assays reveal that only 20% of HT-29 cells adhere to CO IV. However, when these cells start a differentiation process, the proportion of cells adhering to this protein can reach 70%. These changes in HT-29 cell adhesion are not due to an increase in the surface expression of integrins but rather to a switch in the nature of the integrins involved in collagen binding. Indeed, our data indicate that during differentiation α3β1 becomes the major CO IV receptor instead of α2β1.

The possibility that CO IV constitutes a ligand for the α3β1 integrin has been discussed. It has been shown previously that integrins α1β1 and α2β1 are high-affinity receptors for type IV collagen, whereas α3β1 is at best a low-affinity receptor (Kühn and Eble, 1994). Furthermore, in direct ligand binding assays with the use of soluble recombinant α3β1, Eble et al. (1998) showed that α3β1 specifically binds laminin isoforms 5 and 10, but not collagen. This discrepancy with our data suggests that activation of α3β1 is a prerequisite for the recognition of collagen by this integrin. Indeed, melanoma and ovarian carcinoma cells have been shown to use the α3β1 integrin to bind to a sequence in the α1 chain of basement membrane CO IV (amino acids 531–543) (Miles et al., 1995; Lauer et al., 1998). Moreover, an anti-α3 antibody inhibits melanocyte migration on CO IV as well as cell motility (Morelli et al., 1993; Melchiori et al., 1995).

A regulatory role for α3β1 has already been pointed out by other groups and may also apply to other integrins bound to fibronectin and laminin (Dogic et al., 1998). In these studies, the inhibition of α3 integrin function or the deficiency in α3 integrin expression enhanced both the adhesion and the migration of keratinocytes on fibronectin and CO IV (Kim et al., 1992; Hodivala-Dilke et al., 1998, Lichtner et al., 1998). In contrast, we found that activation of α3β1 favored the adhesion of human colon carcinoma cells to CO IV. Thus, it can be postulated that α3β1 generates different effects in the regulation of both adhesion and migration processes, depending on the cell type and the environment. To date, the mechanism by which α3β1 exerts its regulatory role is not clearly unraveled. One hypothesis is that α3β1 may interfere with the formation of typical adhesion complexes by segregating and/or redistributing focal adhesion-associated proteins to another subcellular localization. Alternatively, α3 may interfere directly with the binding of integrins to intracellular proteins present in typical adhesion complexes, by masking or inducing a conformational change in the β1-cytoplasmic domain. Surface plasmon resonance studies revealed that the cytoplasmic domain of the β1 integrin subunit interacts with low affinity with the cytoplasmic tail of the α3 integrin subunit, but not with those of several other α subunits (Laplantine et al., 2000). Another hypothesis is that α3β1 integrin may also regulate the function of other integrins by changing signaling events involved in transduction pathways associated with other integrins. Our results indicated that a RhoA-mediated signaling pathway was responsible for the α2β1/α3β1 integrin switch. The differentiation of HT-29 cells was associated with a decrease in active RhoA-GTP proteins. Active Rho-GTPases may be a limiting factor in epithelial cells. Hence, regulation of their activities and/or subcellular localization by cell-substrate interactions may affect important processes such as intercellular adhesion, differentiation, and migration.

Key Role of Laminin-5 in α3β1 Activation

In HT-29 cells, activation of α3β1 is not constitutive but rather depends on LN 5 secretion. Recent work indicates that the globular module G3 of the LN 5 α3-chain is required for this activation and for rapid cell adhesion and migration (Hirosaki et al., 2000). We found that during the early stage of cell differentiation, HT-29 cells produce more LN 5 that activates α3β1 and switches off α2β1. Both α3 and α6 integrins, which are involved in LN 5 interaction on HT-29 cells, could trigger this switch. Furthermore, once activated the α3β1 integrin becomes a major receptor for collagen. The possibility that the increased adhesion to CO IV is mediated by LN 5 located at the cell surface can be excluded. Indeed, the γ2 chain of LN 5 cannot bind nidogen (Mayer et al., 1995) and therefore LN 5 alone cannot associate with CO IV (Yurchenco et al., 1985; Rousselle et al., 1997). Furthermore, FACS experiments performed with the anti-LN 5 mAb indicated that no LN 5 was detected at the cell surface of HT-29 Gal cells before adhesion (data not shown). The mechanism by which LN 5 induces the integrin switch is probably associated with its effect on signaling pathways and in particular on the level of RhoA-GTP. Similar effects have been described in keratynocytes; Nguyen at al. (2000) showed that deposition of LN 5 onto CO IV substratum induced a change in signaling from a Rho-dependent to a PI3-kinase–dependent pathway.

The effect of LN 5 on integrin activation, which in turn modulates cell adhesion and/or migration, appears to be associated with the stage of epithelial cell differentiation. Treatment of HT-29 cells with anticancer drugs, 5-fluorouacil or methotrexate, generated the clones HT-29FU and HT-29MTX, which are committed to differentiate into specific phenotypes (Lesuffleur et al., 1990, 1991). These differentiated subclones also produce more LN 5 than parental HT-29 cells. In contrast, highly differentiated HT-29 cells or the differentiated colon carcinoma Caco-2 cells produce almost no LN 5 (Orian-Rousseau et al., 1998 and our personal observations). These observations suggest that LN 5 is not involved in the later stages of cell differentiation.

The activation of α3β1 integrin by LN 5 could be mimicked in vitro by low concentrations of P1B5 or ASC1. The mechanism by which these antibodies induced the α3β1 integrin activation is not clear. P1B5 treatment was neither associated with a modification of integrin clustering nor with integrin redistribution as observed in Takeuchi et al. (1994). In HT-29 cells, although α3β1 was localized at the cell surface the integrin did not participate in homotypic adhesion (data not shown). Therefore, we favor the view that PIB5 binding to α3 integrins induces a conformational change that is responsible for their activation. One possible explanation is that at low concentrations of P1B5, this antibody stimulates outside-in signaling of a subpopulation of α3β1 that then activates the remaining α3β1 to bind CO IV. High concentrations of P1B5 may also stimulate these activating signals but would fail to result in increased binding to CO IV, because all α3β1 is bound to P1B5 and unavailable for CO IV binding.

Physiological Implications for Trans-dominant Inhibition Mediated by α3 β1

The switch between α2β1/α3β1 integrins may participate in the differentiation processs that occurs along the crypt-villus unit in at least two ways. First, the substitution for RhoA by α3β1-mediated cell-substrate adhesion may favor E-cadherin–based cell-cell adhesion, a step in the differentiation process that required RhoA proteins (Braga et al., 1997). Second, the activation of α3β1 by LN 5 present in the basement membrane could trigger cell migration along the crypt-villus unit. Indeed, the mechanism of epithelial cell migration in the adult intestine remains obscure, this process probably does not involved a classical cell migration implicating focal adhesions, as well as the detachment of the cell surface receptors as previously described (Lauffenburger and Horwitz, 1996). Probably, it involves instead a sliding of the differentiated cells along the basement membrane of the crypt-villus axis, pushed by the lower proliferative cells. This possibility is emphasized by the fact that most α3β1 integrins are not concentrated into focal adhesions (DiPersio et al., 1995) and that α3β1 is a low-affinity receptor for CO IV.

The involvement of integrin switching during colon cell differentiation is supported by analysis of the expression of integrins and basement membrane molecules in the human intestine (reviewed by Beaulieu, 1999). LN 5 displays a concentration gradient increasing from the base to the tip of the villus (Leivo et al., 1996; Orian-Rousseau et al., 1996). Furthermore, this spatial distribution of LN 5 is associated with a differential crypt-villus pattern of expression for laminin-binding integrins: α2β1 and α3β1 displayed complementary staining patterns for the lower crypt (α2+, α3) and upper crypt-villus regions (α2, α3+) (Beaulieu 1992).

The α3β1 integrin-dependent migration on LN 5 could also be relevant to tumor invasion. Studies of LN 5 expression in various human cancers indicate that this protein is specific to cells of epithelial origin (Pyke et al., 1995). It is noteworthy that in colon adenocarcinomas, the LN 5 staining was invariably associated with budding cancer cells located at the invasive front of the malignant epithelium.

In this study we provide new insight into the key role of α3β1 integrin as a “regulator” integrin of epithelial cell differentiation. Clearly, α3β1 function is more complex than that of a simple adhesion receptor. It appears to modulate events that are mediated by other transmembrane receptors, including integrins and cadherins. A next decisive step will be to unravel the signal transduction cascade involved in α3β1 regulation and function.

ACKNOWLEDGMENTS

We are grateful to Dr. P. Simon-Assmann for helpful discussion. We thank Jean Claire Illes (student at the University Joseph Fourier, Grenoble, France), Geneviève Tavernier, and Brigitte Peyrusse for excellent technical assistance. This work was supported by the Center National de la Recherche Scientifique and a grant (no. 9349) from the Association Contre le Cancer (to P.R.). S.G. is the recipient of a fellowship from the Ministère de la Recherche et de l'Enseignement Supérieur.

Abbreviations used:

CO IV

collagen type IV

LN 5

laminin-5

REFERENCES

  1. Aumailley M, Krieg T. Laminins: a family of diverse multifunctional molecules of basement membranes. J Invest Dermatol. 1996;106:209–214. doi: 10.1111/1523-1747.ep12340471. [DOI] [PubMed] [Google Scholar]
  2. Baker SE, Hopkinson SB, Fitchmun M, Andreason GL, Frasier F, Plopper G, Quaranta V, Jones JC. Laminin-5 and hemidesmosomes: role of the alpha 3 chain subunit in hemidesmosome stability and assembly. J Cell Sci. 1996;109:2509–2520. doi: 10.1242/jcs.109.10.2509. [DOI] [PubMed] [Google Scholar]
  3. Beaulieu JF. Differential expression of the VLA family of integrins along the crypt-villus axis in the human small intestine. J Cell Sci. 1992;102:427–436. doi: 10.1242/jcs.102.3.427. [DOI] [PubMed] [Google Scholar]
  4. Beaulieu JF. Extracellular matrix components and integrins in relationship to human intestin epithelial cell differentiation. Prog Histochem Cytochem. 1997;314:1–78. doi: 10.1016/s0079-6336(97)80001-0. [DOI] [PubMed] [Google Scholar]
  5. Beaulieu JF. Integrins and human intestinal cell functions. Front Biosci. 1999;4:D310–D321. doi: 10.2741/beaulieu. [DOI] [PubMed] [Google Scholar]
  6. Braga VM, Machesky LM, Hall A, Hotchin NA. The small GTPases Rho and Rac are required for the establishment of cadherin-dependent cell-cell contacts. J Cell Biol. 1997;137:1421–1431. doi: 10.1083/jcb.137.6.1421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Carter WG, Kaur P, Gil SG, Gahr PJ, Wayner EA. Distinct functions for integrins alpha 3 beta 1 in focal adhesions and alpha 6 beta 4/bullous pemphigoid antigen in a new stable anchoring contact (SAC) of keratinocytes: relation to hemidesmosomes. J Cell Biol. 1990a;111:3141–3154. doi: 10.1083/jcb.111.6.3141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Carter WG, Wayner EA, Bouchard TS, Kaur P. The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells. J Cell Biol. 1990b;110:1387–1404. doi: 10.1083/jcb.110.4.1387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. De Arcangelis A, Neuville P, Boukamel R, Lefebvre O, Kedinger M, Simon-Assmann P. Inhibition of laminin alpha 1-chain expression leads to alteration of basement membrane assembly and cell differentiation. J Cell Biol. 1996;133:417–430. doi: 10.1083/jcb.133.2.417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dedhar S, Jewell K, Rojiani M, Gray V. The receptor for the basement membrane glycoprotein entactin is the integrin alpha 3/beta 1. J Biol Chem. 1992;267:18908–18914. [PubMed] [Google Scholar]
  11. DeFreitas MF, Yoshida CK, Frazier WA, Mendrick DL, Kypta RM, Reichardt LF. Identification of integrin alpha 3 beta 1 as a neuronal thrombospondin receptor mediating neurite outgrowth. Neuron. 1995;15:333–343. doi: 10.1016/0896-6273(95)90038-1. [DOI] [PubMed] [Google Scholar]
  12. DiPersio CM, Shah S, Hynes RO. alpha 3A beta 1 integrin localizes to focal contacts in response to diverse extracellular matrix proteins. J Cell Sci. 1995;108:2321–2336. doi: 10.1242/jcs.108.6.2321. [DOI] [PubMed] [Google Scholar]
  13. Dogic D, Rousselle P, Aumailley M. Cell adhesion to laminin 1 or 5 induces isoform-specific clustering of integrins and other focal adhesion components. J Cell Sci. 1998;111:793–802. doi: 10.1242/jcs.111.6.793. [DOI] [PubMed] [Google Scholar]
  14. Eagle H, Barban S, Levy M, Schulze HO. The utilization of carbohydrates by human cell cultures. J Biol Chem. 1958;233:551–558. [PubMed] [Google Scholar]
  15. Eble JA, Wucherpfennig KW, Gauthier L, Dersch P, Krukonis E, Isberg RR, Hemler ME. Recombinant soluble human alpha 3 beta 1 integrin: purification, processing, regulation, and specific binding to laminin-5 and invasin in a mutually exclusive manner. Biochemistry. 1998;37:10945–10955. doi: 10.1021/bi980175+. [DOI] [PubMed] [Google Scholar]
  16. Ekblom M, Falk M, Salmivirta K, Durbeej M, Ekblom P. Laminin isoforms and epithelial development. Ann NY Acad Sci. 1998;857:194–211. doi: 10.1111/j.1749-6632.1998.tb10117.x. [DOI] [PubMed] [Google Scholar]
  17. Elices MJ, Urry LA, Hemler ME. Receptor functions for the integrin VLA-3: fibronectin, collagen, and laminin binding are differentially influenced by Arg-Gly-Asp peptide and by divalent cations. J Cell Biol. 1991;112:169–181. doi: 10.1083/jcb.112.1.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Engvall E, Ruoslahti E. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer. 1977;20:1–5. doi: 10.1002/ijc.2910200102. [DOI] [PubMed] [Google Scholar]
  19. Fantini J, Rognoni JB, Culouscou JM, Pommier G, Marvaldi J, Tirard A. Induction of polarized apical expression and vectorial release of carcinoembryonic antigen (CEA) during the process of differentiation of HT29–D4 cells. J Cell Physiol. 1989;141:126–134. doi: 10.1002/jcp.1041410119. [DOI] [PubMed] [Google Scholar]
  20. Gonzales M, Haan K, Baker SE, Fitchmun M, Todorov I, Weitzman S, Jones JC. A cell signal pathway involving laminin-5, alpha3beta1 integrin, and mitogen-activated protein kinase can regulate epithelial cell proliferation. Mol Biol Cell. 1999;10:259–270. doi: 10.1091/mbc.10.2.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Green KJ, Jones JC. Desmosomes and hemidesmosomes: structure and function of molecular components. FASEB J. 1996;10:871–881. doi: 10.1096/fasebj.10.8.8666164. [DOI] [PubMed] [Google Scholar]
  22. Hirosaki T, Mizushima H, Tsubota Y, Moriyama K, Miyazaki K. Structural requirement of carboxyl-terminal globular domains of laminin alpha 3 chain for promotion of rapid cell adhesion, and migration by laminin-5. J Biol Chem. 2000;275:22495–22502. doi: 10.1074/jbc.M001326200. [DOI] [PubMed] [Google Scholar]
  23. Hodivala-Dilke KM, DiPersio CM, Kreidberg JA, Hynes RO. Novel roles for alpha3beta1 integrin as a regulator of cytoskeletal assembly and as a trans-dominant inhibitor of integrin receptor function in mouse keratinocytes. J Cell Biol. 1998;142:1357–1369. doi: 10.1083/jcb.142.5.1357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Huet C, Sahuquillo-Merino C, Coudrier E, Louvard D. Absorptive and mucus-secreting subclones isolated from a multipotent intestinal cell line (HT-29) provide new models for cell polarity and terminal differentiation. J Cell Biol. 1987;105:345–357. doi: 10.1083/jcb.105.1.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69:11–25. doi: 10.1016/0092-8674(92)90115-s. [DOI] [PubMed] [Google Scholar]
  26. Jewell K, Kapron-Bras C, Jeevaratnam P, Dedhar S. Stimulation of tyrosine phosphorylation of distinct proteins in response to antibody-mediated ligation and clustering of alpha 3 and alpha 6 integrins. J Cell Sci. 1995;108:1165–1174. doi: 10.1242/jcs.108.3.1165. [DOI] [PubMed] [Google Scholar]
  27. Kim JP, Zhang K, Kramer RH, Schall TJ, Woodley DT. Integrin receptors and RGD sequences in human keratinocyte migration: unique anti-migratory function of alpha 3 beta 1 epiligrin receptor. J Invest Dermatol. 1992;98:764–770. doi: 10.1111/1523-1747.ep12499947. [DOI] [PubMed] [Google Scholar]
  28. Kreidberg JA. Functions of a3b1 integrin. Curr Opin Cell Biol. 2000;12:548–553. doi: 10.1016/s0955-0674(00)00130-7. [DOI] [PubMed] [Google Scholar]
  29. Kühn K, Eble J. The structural bases of integrin-ligand interactions. Trends Cell Biol. 1994;4:256–261. doi: 10.1016/0962-8924(94)90124-4. [DOI] [PubMed] [Google Scholar]
  30. Lampe PD, Nguyen BP, Gil S, Usui M, Olerud J, Takada Y, Carter WG. Cellular interaction of integrin alpha3beta1 with laminin 5 promotes gap junctional communication. J Cell Biol. 1998;143:1735–1747. doi: 10.1083/jcb.143.6.1735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Laplantine E, Vallar L, Mann K, Kieffer N, Aumailley M. Interaction between the cytodomains of the alpha 3 and beta 1 integrin subunits regulates remodelling of adhesion complexes on laminin. J Cell Sci. 2000;113:1167–1176. doi: 10.1242/jcs.113.7.1167. [DOI] [PubMed] [Google Scholar]
  32. Lauer JL, Gendron CM, Fields GB. Effect of ligand conformation on melanoma cell alpha3beta1 integrin-mediated signal transduction events: implications for a collagen structural modulation mechanism of tumor cell invasion. Biochemistry. 1998;37:5279–5287. doi: 10.1021/bi972958l. [DOI] [PubMed] [Google Scholar]
  33. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell. 1996;84:359–369. doi: 10.1016/s0092-8674(00)81280-5. [DOI] [PubMed] [Google Scholar]
  34. Le Bivic A, Arsanto JP. Differential expression of alkaline phosphatase and ATPase activities in human colon carcinoma cell line HT-29.18 during differentiation. Biol Cell. 1987;60:41–47. doi: 10.1111/j.1768-322x.1987.tb00544.x. [DOI] [PubMed] [Google Scholar]
  35. Leblond CP. The life history of cells in renewing systems. Am J Anat. 1981;160:114–159. doi: 10.1002/aja.1001600202. [DOI] [PubMed] [Google Scholar]
  36. Leivo I, Tani T, Laitinen L, Bruns R, Kivilaakso E, Lehto VP, Burgeson RE, Virtanen I. Anchoring complex components laminin-5 and type VII collagen in intestine: association with migrating and differentiating enterocytes. J Histochem Cytochem. 1996;44:1267–1277. doi: 10.1177/44.11.8918902. [DOI] [PubMed] [Google Scholar]
  37. Lesuffleur T, Barbat A, Dussaulx E, Zweibaum A. Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res. 1990;50:6334–6343. [PubMed] [Google Scholar]
  38. Lesuffleur T, Kornowski A, Luccioni C, Muleris M, Barbat A, Beaumatin J, Dussaulx E, Dutrillaux B, Zweibaum A. Adaptation to 5-fluorouracil of the heterogeneous human colon tumor cell line HT-29 results in the selection of cells committed to differentiation. Int J Cancer. 1991;49:721–730. doi: 10.1002/ijc.2910490516. [DOI] [PubMed] [Google Scholar]
  39. Lichtner RB, Howlett AR, Lerch M, Xuan J-A, Brink J, Langton-Webster B, Schneider MR. Negative cooperativity between α3β1 and α2β1 integrins in human mammary carcinoma MDA MB231 cells. Exp Cell Res. 1998;240:368–376. doi: 10.1006/excr.1998.4012. [DOI] [PubMed] [Google Scholar]
  40. Louvard D, Kedinger M, Hauri HP. The differentiating intestinal epithelial cell: establishment and maintenance of functions through interactions between cellular structures. Annu Rev Cell Biol. 1992;8:157–195. doi: 10.1146/annurev.cb.08.110192.001105. [DOI] [PubMed] [Google Scholar]
  41. Mayer UE, Poschl E, Gerecke DR, Wagman DW, Burgeson RE, Timpl R. Low nidogen affinity of laminin-5 can be attributed to two serine residues in EGF-like motive γ2III4. FEBS Lett. 1995;365:129–132. doi: 10.1016/0014-5793(95)00438-f. [DOI] [PubMed] [Google Scholar]
  42. Mainiero F, Pepe A, Wary KK, Spinardi L, Mohammadi M, Schlessinger J, Giancotti FG. Signal transduction by the alpha 6 beta 4 integrin: distinct beta 4 subunit sites mediate recruitment of Shc/Grb2 and association with the cytoskeleton of hemidesmosomes. EMBO J. 1995;14:4470–4481. doi: 10.1002/j.1460-2075.1995.tb00126.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Melchiori A, Mortarini R, Carlone S, Marchisio PC, Anichini A, Noonan DM, Albini A. The alpha 3 beta 1 integrin is involved in melanoma cell migration and invasion. Exp Cell Res. 1995;219:233–242. doi: 10.1006/excr.1995.1223. [DOI] [PubMed] [Google Scholar]
  44. Miles AJ, Knutson JR, Skubitz AP, Furcht LT, McCarthy JB, Fields GB. A peptide model of basement membrane collagen alpha 1 (IV) 531–543 binds the alpha 3 beta 1 integrin. J Biol Chem. 1995;270:29047–29050. doi: 10.1074/jbc.270.49.29047. [DOI] [PubMed] [Google Scholar]
  45. Miyamoto S, Teramoto H, Coso OA, Gutkind JS, Burbelo PD, Akiyama SK, Yamada KM. Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J Cell Biol. 1995;131:791–805. doi: 10.1083/jcb.131.3.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Morelli JG, Yohn JJ, Zekman T, Norris DA. Melanocyte movement in vitro: role of matrix proteins and integrin receptors. J Invest Dermatol. 1993;101:605–608. doi: 10.1111/1523-1747.ep12366064. [DOI] [PubMed] [Google Scholar]
  47. Nguyen BP, Gil SG, Carter WG. Deposition of laminin 5 by keratinocytes regulates integrin adhesion and signaling. J Biol Chem. 2000;275:31896–31901. doi: 10.1074/jbc.M006379200. [DOI] [PubMed] [Google Scholar]
  48. Orian-Rousseau V, Aberdam D, Fontao L, Chevalier L, Meneguzzi G, Kedinger M, Simon-Assmann P. Developmental expression of laminin-5 and HD1 in the intestine: epithelial to mesenchymal shift for the laminin gamma-2 chain subunit deposition. Dev Dyn. 1996;206:12–23. doi: 10.1002/(SICI)1097-0177(199605)206:1<12::AID-AJA2>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  49. Orian-Rousseau V, Aberdam D, Rousselle P, Messent A, Gavrilovic J, Meneguzzi G, Kedinger M, Simon-Assmann P. Human colonic cancer cells synthesize and adhere to laminin-5. Their adhesion to laminin-5 involves multiple receptors among which is integrin alpha2beta1. J Cell Sci. 1998;111:1993–2004. doi: 10.1242/jcs.111.14.1993. [DOI] [PubMed] [Google Scholar]
  50. Pinto M, Appay MD, Simon-Assmann P, Chevalier G, Dracopoli N, Fogh J, Zweibaum A. Enterocytic differentiation of cultured human colon cancer cells by replacement of glucose by galactose in the medium. Biol Cell. 1982;44:193–196. [Google Scholar]
  51. Pyke C, Salo S, Ralfkiaer E, Romer J, Dano K, Tryggvason K. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res. 1995;55:4132–4139. [PubMed] [Google Scholar]
  52. Ren X-D, Kiosses WB, Schwartz MA. regulation of small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J. 1999;18:578–585. doi: 10.1093/emboj/18.3.578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell. 1992;70:389–399. doi: 10.1016/0092-8674(92)90163-7. [DOI] [PubMed] [Google Scholar]
  54. Rousselle P, Aumailley M. Kalinin is more efficient than laminin in promoting adhesion of primary keratinocytes and some other epithelial cells and has a different requirement for integrin receptors. J Cell Biol. 1994;125:205–214. doi: 10.1083/jcb.125.1.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Rousselle P, Keene DR, Ruggiero F, Champliaud M-F, van der Rest M, Burgeson RE. Laminin 5 binds the NC-1 domain of type VII collagen. J Cell Biol. 1997;138:719–728. doi: 10.1083/jcb.138.3.719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Rousselle P, Lunstrum GP, Keene DR, Burgeson RE. Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J Cell Biol. 1991;114:567–576. doi: 10.1083/jcb.114.3.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Ruoslahti E. Integrins. J Clin Invest. 1991;87:1–5. doi: 10.1172/JCI114957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Schreiner C, Bauer J, Margolis M, Juliano RL. Expression and role of integrins in adhesion of human colonic carcinoma cells to extracellular matrix components. Clin Exp Metastasis. 1991;9:163–178. doi: 10.1007/BF01756387. [DOI] [PubMed] [Google Scholar]
  59. Schwartz MA, Schaller MD, Ginsberg MH. Integrins: emerging paradigms of signal transduction. Annu Rev Cell Dev Biol. 1995;11:549–599. doi: 10.1146/annurev.cb.11.110195.003001. [DOI] [PubMed] [Google Scholar]
  60. Sekine A, Fujiwara M, Narumiya S. Asparagine residue in the rho gene product is the modification site for the botulinum ADP-ribosyltransferase. J Biol Chem. 1989;264:8602–8605. [PubMed] [Google Scholar]
  61. Simon-Assmann P, Kedinger M, De Arcangelis A, Rousseau V, Simo P. Extracellular matrix components in intestinal development. Experientia. 1995;51:883–900. doi: 10.1007/BF01921739. [DOI] [PubMed] [Google Scholar]
  62. Simon-Assmann P, Leberquier C, Molto N, Uezato T, Bouziges F, Kedinger M. Adhesive properties and integrin expression profiles of two colonic cancer populations differing by their spreading on laminin. J Cell Sci. 1994;107:577–587. doi: 10.1242/jcs.107.3.577. [DOI] [PubMed] [Google Scholar]
  63. Simon-Assmann P, Lefebvre O, Bellissent-Waydelich A, Olsen J, Orian-Rousseau V, De Arcangelis A. The laminins: role in intestinal morphogenesis and differentiation. Ann NY Acad Sci. 1998;859:46–64. doi: 10.1111/j.1749-6632.1998.tb11110.x. [DOI] [PubMed] [Google Scholar]
  64. Simoneau A, Herring-Gillam FE, Vachon PH, Perreault N, Basora N, Bouatrouss Y, Pageot LP, Zhou J, Beaulieu JF. Identification, distribution, and tissular origin of the alpha5(IV) and alpha6(IV) collagen chains in the developing human intestine. Dev Dyn. 1998;212:437–447. doi: 10.1002/(SICI)1097-0177(199807)212:3<437::AID-AJA11>3.0.CO;2-Y. [DOI] [PubMed] [Google Scholar]
  65. Stieger B, Marxer A, Hauri HP. Isolation of brush-border membranes from rat and rabbit colonocytes: is alkaline phosphatase a marker enzyme? J Membr Biol. 1986;91:19–31. doi: 10.1007/BF01870211. [DOI] [PubMed] [Google Scholar]
  66. Symington BE, Carter WG. Modulation of epidermal differentiation by epiligrin and integrin alpha 3 beta 1. J Cell Sci. 1995;108:831–838. doi: 10.1242/jcs.108.2.831. [DOI] [PubMed] [Google Scholar]
  67. Takeuchi K, Tsuji T, Hakomori S, Irimura T. Intercellular adhesion induced by anti-alpha 3 integrin (VLA-3) antibodies. Exp Cell Res. 1994;211:133–141. doi: 10.1006/excr.1994.1069. [DOI] [PubMed] [Google Scholar]
  68. Tamura RN, Cooper HM, Collo G, Quaranta V. Cell type-specific integrin variants with alternative alpha chain cytoplasmic domains. Proc Natl Acad Sci USA. 1991;88:10183–10187. doi: 10.1073/pnas.88.22.10183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Timpl R. Macromolecular organization of basement membranes. Curr Opin Cell Biol. 1996;8:618–624. doi: 10.1016/s0955-0674(96)80102-5. [DOI] [PubMed] [Google Scholar]
  70. Vachon PH, Beaulieu JF. Extracellular heterotrimeric laminin promotes differentiation in human enterocytes. Am J Physiol. 1995;268:G857–G867. doi: 10.1152/ajpgi.1995.268.5.G857. [DOI] [PubMed] [Google Scholar]
  71. Wang Z, Symons JM, Goldstein SL, McDonald A, Miner JH, Kreidberg JA. (Alpha)3(beta)1 integrin regulates epithelial cytoskeletal organization. J Cell Sci. 1999;112:2925–2935. doi: 10.1242/jcs.112.17.2925. [DOI] [PubMed] [Google Scholar]
  72. Wayner EA, Carter WG. Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique a and common b subunits. J Cell Biol. 1987;105:1873–1884. doi: 10.1083/jcb.105.4.1873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Wice BM, Trugnan G, Pinto M, Rousset M, Chevalier G, Dussaulx E, Lacroix B, Zweibaum A. The intracellular accumulation of UDP-N-acetylhexosamines is concomitant with the inability of human colon cancer cells to differentiate. J Biol Chem. 1985;260:139–146. [PubMed] [Google Scholar]
  74. Xia Y, Gil SG, Carter WG. Anchorage mediated by integrin alpha6beta4 to laminin 5 (epiligrin) regulates tyrosine phosphorylation of a membrane-associated 80-kD protein. J Cell Biol. 1996;132:727–740. doi: 10.1083/jcb.132.4.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Yurchenco PD, Tsilibary EC, Charonis AS, Furthmayr H. Binding of laminin to type IV collagen: a morphological study. J BiolChem. 1985;260:7636–7644. doi: 10.1083/jcb.100.6.1848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Zweibaum A, Pinto M, Chevalier G, Dussaulx E, Triadou N, Lacroix B, Haffen K, Brun JL, Rousset M. Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose. J Cell Physiol. 1985;122:21–29. doi: 10.1002/jcp.1041220105. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Biology of the Cell are provided here courtesy of American Society for Cell Biology

RESOURCES